| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-8993(98)01282-7 |
| P698 | PubMed publication ID | 9914438 |
| P2093 | author name string | Franke H | |
| Galla HJ | |||
| Beuckmann CT | |||
| P2860 | cites work | Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability | Q48729747 |
| Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions | Q69504812 | ||
| Absence of microwave effect on blood-brain barrier permeability to [14C]sucrose in the conscious rat | Q70426694 | ||
| Induction of the blood/brain-barrier-associated enzyme alkaline phosphatase in endothelial cells from cerebral capillaries is mediated via cAMP | Q72257210 | ||
| Adult rabbit brain synthesizes retinoic acid | Q72343459 | ||
| Measurement of protein using bicinchoninic acid | Q26778491 | ||
| Induction of blood-brain barrier characteristics in bovine brain endothelial cells by rat astroglial cells in transfilter coculture | Q34007143 | ||
| Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults | Q34056959 | ||
| Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability | Q34057451 | ||
| Hydrocortisone reinforces the blood-brain properties in a serum free cell culture system | Q34067059 | ||
| Hot spots of retinoic acid synthesis in the developing spinal cord. | Q35620973 | ||
| Failure of hyperthermia to open rat blood-brain barrier: reduced permeation of sucrose | Q40847445 | ||
| Determination of binding affinities of retinoids to retinoic acid-binding protein and serum albumin | Q41886137 | ||
| A cell culture model of the blood-brain barrier | Q42006322 | ||
| Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models | Q42041789 | ||
| Inhibition of blood-brain barrier permeability to DL-propranolol by serum from acute renal failure rats | Q48194173 | ||
| Basement membrane proteins influence brain capillary endothelial barrier function in vitro. | Q48403823 | ||
| Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier | Q48503223 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | blood–brain barrier | Q221694 |
| haloperidol | Q251347 | ||
| P304 | page(s) | 65-71 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol | |
| P478 | volume | 818 |
| Q36959330 | A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells |
| Q40247031 | A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine |
| Q28540639 | A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug |
| Q36609859 | A novel brain neurovascular unit model with neurons, astrocytes and microvascular endothelial cells of rat. |
| Q50177856 | Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier |
| Q40554063 | Barrier functionality of porcine and bovine brain capillary endothelial cells |
| Q37010459 | Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds |
| Q35850574 | Blood-Brain Barrier Effects of the Fusarium Mycotoxins Deoxynivalenol, 3 Acetyldeoxynivalenol, and Moniliformin and Their Transfer to the Brain |
| Q52141712 | Blood-brain barrier properties in vitro depend on composition and assembly of endogenous extracellular matrices. |
| Q38100970 | Blood-brain barrier structure and function and the challenges for CNS drug delivery |
| Q30993376 | Brain microvessel endothelial cells responses to gold nanoparticles: In vitro pro-inflammatory mediators and permeability |
| Q26827093 | Cell-culture models of the blood-brain barrier |
| Q44410490 | Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood–brain barrier |
| Q31807521 | Characterization of 3-[(123)I]iodo-L-alpha-methyl tyrosine transport in astrocytes of neonatal rats |
| Q35946021 | Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases |
| Q46277820 | Effects of arsenolipids on in vitro blood-brain barrier model |
| Q36495399 | Electroporation of Brain Endothelial Cells on Chip toward Permeabilizing the Blood-Brain Barrier |
| Q64937657 | Embelin, a Potent Molecule for Alzheimer's Disease: A Proof of Concept From Blood-Brain Barrier Permeability, Acetylcholinesterase Inhibition and Molecular Docking Studies. |
| Q36959343 | Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance |
| Q34117779 | Establishment of an in vitro brain barrier epithelial transport system for pharmacological and toxicological study |
| Q40624908 | Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier |
| Q40624723 | Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies |
| Q39910823 | Evaluation of the selected barrier properties of retinal pigment epithelial cell line ARPE-19 for an in-vitro blood-brain barrier model |
| Q37698934 | Experimental methods and transport models for drug delivery across the blood-brain barrier |
| Q48543732 | Generic fast gradient liquid chromatography/tandem mass spectrometry techniques for the assessment of the in vitro permeability across the blood-brain barrier in drug discovery |
| Q34214692 | How does the benzamide antipsychotic amisulpride get into the brain?--An in vitro approach comparing amisulpride with clozapine |
| Q36006864 | Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro. |
| Q41915054 | Impedance-based cell monitoring: barrier properties and beyond |
| Q47672573 | Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells. |
| Q42022769 | In vitro intestinal bioavailability of arsenosugar metabolites and presystemic metabolism of thio-dimethylarsinic acid in Caco-2 cells |
| Q89057060 | In vitro models of molecular and nano-particle transport across the blood-brain barrier |
| Q39356621 | Influence of T-2 and HT-2 toxin on the blood-brain barrier in vitro: new experimental hints for neurotoxic effects |
| Q38730069 | In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. |
| Q51007359 | Measuring direct current trans-epithelial electrical resistance in organ-on-a-chip microsystems. |
| Q38117056 | Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research |
| Q31034258 | Methods to assess drug permeability across the blood-brain barrier |
| Q45933505 | Microfluidic passive permeability assay using nanoliter droplet interface lipid bilayers. |
| Q49601349 | Modeling Neurovascular Disorders and Therapeutic Outcomes with Human-Induced Pluripotent Stem Cells |
| Q34005458 | Modelling of the blood-brain barrier in drug discovery and development. |
| Q34775079 | Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier |
| Q44650856 | Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions |
| Q24609936 | Paracellular tightness and claudin-5 expression is increased in the BCEC/astrocyte blood-brain barrier model by increasing media buffer capacity during growth |
| Q41353684 | Permeability of ergot alkaloids across the blood-brain barrier in vitro and influence on the barrier integrity |
| Q36166111 | Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. |
| Q38174718 | Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles |
| Q74038326 | Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro |
| Q48175023 | Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting. |
| Q41710205 | Primary porcine brain microvessel endothelial cell isolation and culture |
| Q48939114 | Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties |
| Q44528945 | Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro |
| Q33659863 | Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells |
| Q39391621 | Surface decoration by Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium nanoparticles |
| Q28086851 | TEER measurement techniques for in vitro barrier model systems |
| Q48475323 | The biocompatibility of a polyelectrolyte vitreous body substitute on a high resistance in vitro model of the blood-retinal barrier |
| Q38134725 | The blood-brain barrier: an engineering perspective. |
| Q48250186 | The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study |
| Q83013066 | The role of the transition metal copper and the ionophore A23187 in the development of Irinophore C™ |
| Q48408724 | The use of in vitro cell culture models for mechanistic studies and as permeability screens for the blood-brain barrier in the pharmaceutical industry--background and current status in the drug discovery process |
| Q36015680 | Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells |
| Q38072037 | Toxicology and clinical potential of nanoparticles |
| Q28484085 | Transcellular targeting of fiber- and hexon-modified adenovirus vectors across the brain microvascular endothelial cells in vitro |
| Q38905979 | Transporter effects on cell permeability in drug delivery |
| Q37181851 | Use of Z310 cells as an in vitro blood-cerebrospinal fluid barrier model: tight junction proteins and transport properties |
Search more.